Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 23 peer-reviewed journal articles Updated

Understanding Familial Hypercholesterolemia

At a Glance

Familial hypercholesterolemia (FH) is an inherited condition that makes it hard for the liver to clear LDL, or “bad,” cholesterol from the blood. It can affect children and adults, so early treatment, healthy habits, and screening close relatives are important.

Hearing that you or your child has high cholesterol can be confusing and even overwhelming, especially if you lead a healthy, active lifestyle. It is important to know that Familial Hypercholesterolemia (FH) is a common but often invisible genetic condition that is not caused by diet, exercise, or willpower, although a healthy lifestyle remains an important part of treatment [1][2].

If you are feeling shocked or even a sense of guilt as a parent, please know that these are normal reactions [3]. FH is an inherited disorder that begins at birth, meaning the body is simply not built to clear cholesterol efficiently on its own [4]. Diagnosis is an opportunity for early intervention that can significantly protect long-term heart health [5].

The Biological “Filter” System

To understand FH, it helps to think of your liver as a filter for your blood. Your body produces LDL (low-density lipoprotein), often called “bad” cholesterol. In a typical body, the liver uses specialized “docking stations” called LDLR (LDL receptors) to pull that cholesterol out of the blood and break it down [6].

In people with FH, this filtering system is impaired because of a mutation in one of three primary genes:

  • LDLR: This is the most common gene involved. The mutation causes the “docking stations” to be missing or broken, so the cholesterol stays in the bloodstream [7][8].
  • APOB: This gene provides the instructions for the “key” on the LDL particle. If the key is the wrong shape, it cannot fit into the liver’s docking station [9].
  • PCSK9: This gene controls how many docking stations are available. In some types of FH, this gene is overactive and destroys the docking stations too quickly [10].

The FH Spectrum: HeFH and HoFH

FH is not a “one size fits all” condition. It exists on a spectrum depending on how many mutated genes a person inherits.

Heterozygous FH (HeFH)

This is the most common form, occurring when a person inherits one mutated gene from one parent and a healthy gene from the other [11].

  • Frequency: Approximately 1 in 250 to 300 people worldwide have HeFH [12][13].
  • Impact: Because one gene still works, the liver can still clear some cholesterol, but levels remain significantly higher than average from birth [14].

Homozygous FH (HoFH)

This is a much rarer and more severe form, occurring when a person inherits mutated genes from both parents [11].

  • Frequency: It is estimated to affect roughly 1 in 300,000 people, though it may be more common than previously thought [12][15].
  • Impact: With both genes affected, the “filter” system works very poorly or not at all. LDL levels are often extremely high (sometimes over 500 mg/dL) even in early childhood [16].

It is important to remember that these are not rigid boxes. HeFH and HoFH can have overlapping cholesterol levels because residual LDL-receptor function, the specific variant type, and other genetic factors vary between individuals [17]. Your care team will look at your genetic results and your cholesterol levels together to determine the best path forward [11].

Why FH is Often “Hidden”

Despite being one of the most common genetic conditions, FH is widely underdiagnosed [18]. There are several reasons why it might not be caught until later in life:

  1. No Symptoms: High cholesterol doesn’t usually cause pain or physical symptoms in childhood or young adulthood [14].
  2. The “Lifestyle” Assumption: Many people (including some healthcare providers) assume high cholesterol is always caused by eating too much saturated fat or not exercising enough, leading them to overlook genetic causes in young or fit people [2][1].
  3. Incomplete Family History: If relatives passed away young or didn’t have their cholesterol checked, the genetic pattern might not be obvious [19].

Taking the Next Steps

Finding out about FH is the first step in changing the narrative for your family. Because FH is inherited, once one person is diagnosed, it is standard care to screen first-degree relatives (parents, siblings, and children)—a process called cascade testing [20][21].

While a healthy lifestyle is still very important for overall health, it is rarely enough on its own to manage FH [22]. Most people with FH will need medication to help their liver “filter” cholesterol properly, and starting this process early is the best way to ensure a healthy future [5][23].

Common questions in this guide

What causes familial hypercholesterolemia?
Familial hypercholesterolemia is caused by an inherited mutation in the LDLR, APOB, or PCSK9 gene that makes it harder for the liver to remove LDL cholesterol from the blood. It begins at birth and is not caused by diet, exercise, or willpower, although healthy habits still support treatment.
How are heterozygous and homozygous FH different?
Heterozygous FH, or HeFH, usually results when a person inherits one changed gene, while homozygous FH, or HoFH, results from changed genes inherited from both parents. HoFH is rarer and often more severe, but cholesterol levels can overlap, so clinicians consider genetic results and LDL levels together.
Can you have familial hypercholesterolemia without symptoms?
Yes. FH often causes no pain or other noticeable physical symptoms during childhood or young adulthood, so it may be found only after cholesterol testing or a family diagnosis. This is why screening and early evaluation are important.
Should my relatives be tested for familial hypercholesterolemia?
Yes. Because FH is inherited, first-degree relatives—parents, siblings, and children—should discuss cholesterol screening and, when appropriate, genetic testing with a healthcare professional. This family-based approach is called cascade testing.
Can diet and exercise lower FH cholesterol enough?
A healthy diet and regular physical activity are important for overall health, but lifestyle changes alone are rarely enough to manage FH. Most people with FH also need cholesterol-lowering medication, with the treatment plan based on their cholesterol levels and clinical situation.
Does an FH diagnosis require a genetic test?
Not necessarily. A healthcare team may use genetic test results, LDL cholesterol levels, or both to diagnose FH and understand whether one or two genes are affected. Genetic findings and cholesterol levels are interpreted together because HeFH and HoFH can have overlapping levels.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Do I (or does my child) have one or two genetic mutations linked to FH?
  2. 2.Is my diagnosis based on a genetic test result, my LDL levels, or both?
  3. 3.Can you explain which gene is affected in our case—LDLR, APOB, or PCSK9—and what that means for our treatment plan?
  4. 4.Does our current LDL level put us in the 'heterozygous' or 'homozygous' range, or somewhere in between?
  5. 5.How should I approach telling my siblings, parents, or other relatives about this diagnosis so they can get screened?
  6. 6.Since this is genetic, how much can we realistically expect diet and exercise to lower these numbers?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (23)
  1. 1

    Familial Hypercholesterolemia: Global Burden and Approaches.

    Tokgozoglu L, Kayikcioglu M

    Current cardiology reports 2021; (23(10)):151 doi:10.1007/s11886-021-01565-5.

    PMID: 34480646
  2. 2

    Familial hypercholesterolemia.

    Sawhney JPS, Madan K

    Indian heart journal 2024; (76 Suppl 1()):S108-S112 doi:10.1016/j.ihj.2023.12.002.

    PMID: 38599725
  3. 3

    A Comprehensive Neuropsychological Study of Familial Hypercholesterolemia and Its Relationship with Psychosocial Functioning: A Biopsychosocial Approach.

    Chan MF, Ganesh A, Mahadevan S, et al.

    Brain sciences 2022; (12(9)) doi:10.3390/brainsci12091127.

    PMID: 36138863
  4. 4

    Molecular basis of familial hypercholesterolemia.

    Bruikman CS, Hovingh GK, Kastelein JJP

    Current opinion in cardiology 2017; (32(3)):262-266 doi:10.1097/HCO.0000000000000385.

    PMID: 28169949
  5. 5

    Familial hypercholesterolemia in children and the importance of early treatment.

    van den Bosch SE, Hutten BA, Corpeleijn WE, Kusters DM

    Current opinion in lipidology 2024; (35(3)):126-132 doi:10.1097/MOL.0000000000000926.

    PMID: 38363694
  6. 6

    Structural dynamics of LDL receptor interactions with E498A and R499G variants of PCSK9.

    Azhar NAA, Chua YA, Nawawi H, Jusoh SA

    Journal of molecular modeling 2025; (31(6)):161 doi:10.1007/s00894-025-06380-1.

    PMID: 40388017
  7. 7

    Recent advances in the management and implementation of care for familial hypercholesterolaemia.

    Lan NSR, Bajaj A, Watts GF, Cuchel M

    Pharmacological research 2023; (194()):106857 doi:10.1016/j.phrs.2023.106857.

    PMID: 37460004
  8. 8

    Genetic Heterogeneity of Familial Hypercholesterolemia: Repercussions for Molecular Diagnosis.

    Di Taranto MD, Fortunato G

    International journal of molecular sciences 2023; (24(4)) doi:10.3390/ijms24043224.

    PMID: 36834635
  9. 9

    Structural analysis of APOB variants, p.(Arg3527Gln), p.(Arg1164Thr) and p.(Gln4494del), causing Familial Hypercholesterolaemia provides novel insights into variant pathogenicity.

    Fernández-Higuero JA, Etxebarria A, Benito-Vicente A, et al.

    Scientific reports 2015; (5()):18184 doi:10.1038/srep18184.

    PMID: 26643808
  10. 10

    PCSK9 and Lipid Metabolism: Genetic Variants, Current Therapies, and Cardiovascular Outcomes.

    Grejtakova D, Boronova I, Bernasovska J, Bellosta S

    Cardiovascular drugs and therapy 2025; (39(6)):1439-1451 doi:10.1007/s10557-024-07599-5.

    PMID: 38907775
  11. 11

    2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance.

    Cuchel M, Raal FJ, Hegele RA, et al.

    European heart journal 2023; (44(25)):2277-2291 doi:10.1093/eurheartj/ehad197.

    PMID: 37130090
  12. 12

    Familial hypercholesterolaemia in children and adolescents: a European Atherosclerosis Society consensus statement.

    Wiegman A, Bourbon M, Freiberger T, et al.

    European heart journal 2026; (47(26)):3324-3346 doi:10.1093/eurheartj/ehag382.

    PMID: 42179051
  13. 13

    Statins for children with familial hypercholesterolemia.

    Vuorio A, Kuoppala J, Kovanen PT, et al.

    The Cochrane database of systematic reviews 2017; (7()):CD006401 doi:10.1002/14651858.CD006401.pub4.

    PMID: 28685504
  14. 14

    The genetics of familial hypercholesterolemia and emerging therapies.

    Vogt A

    The application of clinical genetics 2015; (8()):27-36 doi:10.2147/TACG.S44315.

    PMID: 25670911
  15. 15

    Homozygous Familial Hypercholesterolemia in Spain: Prevalence and Phenotype-Genotype Relationship.

    Sánchez-Hernández RM, Civeira F, Stef M, et al.

    Circulation. Cardiovascular genetics 2016; (9(6)):504-510 doi:10.1161/CIRCGENETICS.116.001545.

    PMID: 27784735
  16. 16

    The clinical and molecular diversity of homozygous familial hypercholesterolemia in children: Results from the GeneTics of clinical homozygous hypercholesterolemia (GoTCHA) study.

    Luirink IK, Braamskamp MJAM, Wiegman A, et al.

    Journal of clinical lipidology 2019; (13(2)):272-278 doi:10.1016/j.jacl.2018.12.003.

    PMID: 30795984
  17. 17

    Genetic Identification of Homozygous Familial Hypercholesterolemia by Long-Read Sequencing Among Patients With Clinically Diagnosed Heterozygous Familial Hypercholesterolemia.

    Chaudhry A, Trinder M, Vesely K, et al.

    Circulation. Genomic and precision medicine 2023; (16(2)):e003887 doi:10.1161/CIRCGEN.122.003887.

    PMID: 36960729
  18. 18

    Update on familial hypercholesterolemia: An expert clinical consensus from the National Lipid Association.

    Ahmad Z, Agarwala A, Cuchel M, et al.

    Journal of clinical lipidology 2026; (20(4)):708-737 doi:10.1016/j.jacl.2026.01.011.

    PMID: 41741298
  19. 19

    An Overview of Familial Hypercholesterolemia in Children and Adolescents-The Story So Far.

    Strati M, Karatza A, Sinopidis X, Kostopoulou E

    Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2026; (32(3)):464-471 doi:10.1016/j.eprac.2025.11.004.

    PMID: 41241276
  20. 20

    Familial hypercholesterolemia in children and adolescents: A clinical perspective.

    de Ferranti SD

    Journal of clinical lipidology 2015; (9(5 Suppl)):S11-9.

    PMID: 26343208
  21. 21

    Clinical Genetic Testing for Familial Hypercholesterolemia: JACC Scientific Expert Panel.

    Sturm AC, Knowles JW, Gidding SS, et al.

    Journal of the American College of Cardiology 2018; (72(6)):662-680 doi:10.1016/j.jacc.2018.05.044.

    PMID: 30071997
  22. 22

    Association of the Interaction Between Familial Hypercholesterolemia Variants and Adherence to a Healthy Lifestyle With Risk of Coronary Artery Disease.

    Fahed AC, Wang M, Patel AP, et al.

    JAMA network open 2022; (5(3)):e222687 doi:10.1001/jamanetworkopen.2022.2687.

    PMID: 35294538
  23. 23

    20-Year Follow-up of Statins in Children with Familial Hypercholesterolemia.

    Luirink IK, Wiegman A, Kusters DM, et al.

    The New England journal of medicine 2019; (381(16)):1547-1556 doi:10.1056/NEJMoa1816454.

    PMID: 31618540

This page is for informational purposes only and does not constitute medical advice. A healthcare professional should interpret your or your child’s cholesterol and genetic results and recommend treatment.

Get notified when new evidence is published on Familial hypercholesterolemia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.